Prospects for new restorative and neuroprotective treatments in Parkinson's disease
- 24 June 1999
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 399 (6738), A32-A39
- https://doi.org/10.1038/399a032
Abstract
The degeneration of forebrain dopamine systems in Parkinson's disease has been an effective target for pharmaceutical research over the past four decades. However, although dopamine replacement may alleviate the symptoms of the disease, it does not halt the underlying neuronal degeneration. The past decade has seen major advances in identifying discrete genetic and molecular causes of parkinsonism and mapping the events involved in nigral cell death. This new understanding of the pathogenesis of the disease now offers novel prospects for therapy based on targeted neuroprotection of vulnerable neurons and effective strategies for their replacement.Keywords
This publication has 86 references indexed in Scilit:
- Glial Cell Line-Derived Neurotrophic Factor Improves Survival of Dopaminergic Neurons in Transplants of Fetal Ventral Mesencephalic TissueExperimental Neurology, 1998
- Mortality in DATATOP: A Multicenter trial in early Parkinson's diseaseAnnals of Neurology, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Neurotrophins Prevent Death and Differentially Affect Tyrosine Hydroxylase of Adult Rat Nigrostriatal Neuronsin VivoExperimental Neurology, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral graftsNeuroReport, 1996
- Generation of DOPA-Producing Astrocytes by Retroviral Transduction of the Human Tyrosine Hydroxylase Gene:In VitroCharacterization andin VivoEffects in the Rat Parkinson ModelExperimental Neurology, 1996
- Mitogenic effect of basic fibroblast growth factor on embryonic ventral mesencephalic dopaminergic neurone precursorsDevelopmental Brain Research, 1993
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopaNeuron, 1991